OPTI CCA-TS2 OPTI 6 GD7046

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,07 report with the FDA on 2015-04-09 for OPTI CCA-TS2 OPTI 6 GD7046 manufactured by Opti Medical Systems Inc..

Event Text Entries

[5635877] On (b)(6) 2015, opti medical confirmed a customer complaint from (b)(6). Customer reported positive bias between 5 g/dl to 7 g/dl in thb measurement relative to the pt's hematology results when using opti ts2 s/n (b)(4). There was no adverse impact to the pt's health condition due to this bias. The discrepant result from the analyzer was not used to make a med decision, e. G. Diagnosis or treatment. The dr indicated that the discrepant result was readily apparent and the pt blood retested using a different instrument.
Patient Sequence No: 1, Text Type: D, B5


[13213723] The results of the tests from the hosp in (b)(6) were reviewed by opti investigation team. It is well understood that hemodialysis can affect thb. During review of the other blood results generated on the affected device, it was noted that the level of potassium measurement was high out of range in the first sample run. A high potassium level is consistent with blood samples that have hemolyzed. Sampling devices and loaner s/n (b)(4) were sent to the customer. The affected analyzer, s/n (b)(4), was returned to opti for investigation. The investigation of the issue using wider range of analyzers determined that some analyzers show a positive bias in the thb measurement that exceeds our specification at low so2 values. The investigation also concluded that the positive bias may be the result of a change in one of the components used in the thb measurement system of the analyzer. As part of the ongoing investigation, results from repeat tests run by the customer using appropriate sampling devices on s/n (b)(4) against i-strat reference and observed positive 2. 5 g/dl to 3. 5 g/dl bias on several samples on (b)(4) 2015. Opti technical personnel visited the hosp to observe the sampling and the testing was repeated on (b)(4) 2015. The positive bias was reproduced. Opti medical is initiating a field correction and removal customer notification in which customers will be requested to not report thb results when using opti cca-ts2 analyzer due to a positive bias in thb. Healthcare professional dr tim skelton (clinical pathologist) stated that a positive bias in thb result may lead to delayed treatment.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3004102403-2015-00001
MDR Report Key4684334
Report Source01,05,07
Date Received2015-04-09
Date of Report2015-04-09
Date of Event2015-02-23
Date Mfgr Received2015-03-11
Device Manufacturer Date2014-08-19
Date Added to Maude2015-05-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactAGHASI CHITCHYAN
Manufacturer Street235 HEMBREE PARK DRIVE
Manufacturer CityROSWELL GA 30076
Manufacturer CountryUS
Manufacturer Postal30076
Manufacturer Phone7706881723
Single Use3
Remedial ActionNO
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOPTI CCA-TS2
Product CodeGKR
Date Received2015-04-09
Model NumberOPTI 6
Catalog NumberGD7046
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerOPTI MEDICAL SYSTEMS INC.
Manufacturer Address235 HEMBREE PARK DRIVE ROSWELL GA 30076 US 30076


Patients

Patient NumberTreatmentOutcomeDate
10 2015-04-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.